NASDAQ:DFNS Nukkleus (DFNS) Stock Price, News & Analysis $37.10 -0.85 (-2.24%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Nukkleus Stock (NASDAQ:DFNS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nukkleus alerts:Sign Up Key Stats Today's Range$35.25▼$40.3550-Day Range$3.90▼$84.9852-Week Range$3.70▼$1,948.75Volume483,951 shsAverage Volume9.72 million shsMarket Capitalization$28.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingModerate Buy Company Overview Nukkleus Inc., a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions. Nukkleus Inc. was founded in 2013 and is headquartered in Jersey City, New Jersey. Read More Nukkleus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreDFNS MarketRank™: Nukkleus scored higher than 12% of companies evaluated by MarketBeat, and ranked 604th out of 651 stocks in the industrials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.7 / 5Analyst RatingModerate Buy Consensus RatingNukkleus has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageNukkleus has only been the subject of 2 research reports in the past 90 days.Read more about Nukkleus' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Nukkleus are expected to decrease in the coming year, from ($4.21) to ($7.27) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nukkleus is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nukkleus is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1,993.95% of the float of Nukkleus has been sold short.Short Interest Ratio / Days to CoverNukkleus has a short interest ratio ("days to cover") of 0.36, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nukkleus has recently increased by 48.46%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNukkleus does not currently pay a dividend.Dividend GrowthNukkleus does not have a long track record of dividend growth. News and Social Media1.3 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Nukkleus this week, compared to 4 articles on an average week.Search Interest36 people have searched for DFNS on MarketBeat in the last 30 days. This is an increase of 414% compared to the previous 30 days.MarketBeat Follows5 people have added Nukkleus to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nukkleus insiders have not sold or bought any company stock.Percentage Held by Insiders11.14% of the stock of Nukkleus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions12.47% of the stock of Nukkleus is held by institutions.Read more about Nukkleus' insider trading history. Receive DFNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nukkleus and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DFNS Stock News HeadlinesTop Blockchain Stocks To Add to Your Watchlist - August 5thAugust 7 at 4:05 AM | americanbankingnews.comT3 Defense Subsidiary Tiltan Receives Purchase Order from Leading Israeli Defense Contractor for Next-Generation Infrared Electro-Optical Simulation ProgramAugust 4, 2026 | globenewswire.comThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.August 10 at 1:00 AM | Investors Alley (Ad)T3 Defense Inc. Subsidiaries Rimon and Tiltan Deliver Strong Year-to-Date Operating PerformanceJuly 31, 2026 | globenewswire.comT3 Defense Subsidiary ITS Delivers Advanced Composite Materials Production Line to Leading Building Materials Manufacturer, Bringing Defense-Proven Fiberglass Technology to Industrial ScaleJuly 20, 2026 | globenewswire.comT3 Defense Announces Reverse Stock SplitJuly 16, 2026 | globenewswire.comT3 Defense Subsidiary Rimon Delivers $1.1 Million Order with Major Israeli Defense Customer for Advanced Elevated Battlefield Lighting SystemsJuly 13, 2026 | globenewswire.comT3 Defense Acquires Majority Stake in Project35, Accelerating Leadership in the Drone and Counter-UAV MarketJuly 10, 2026 | globenewswire.comSee More Headlines DFNS Stock Analysis - Frequently Asked Questions How have DFNS shares performed this year? Nukkleus' stock was trading at $503.75 at the beginning of the year. Since then, DFNS stock has decreased by 92.6% and is now trading at $37.10. How were Nukkleus' earnings last quarter? Nukkleus Inc. (NASDAQ:DFNS) posted its quarterly earnings data on Wednesday, May, 20th. The company reported ($142.50) EPS for the quarter. The firm had revenue of $3.65 million for the quarter. When did Nukkleus' stock split? Shares of Nukkleus reverse split before market open on Thursday, October 24th 2024.The 1-8 reverse split was announced on Friday, October 18th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of Nukkleus? Shares of DFNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nukkleus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nukkleus investors own include Lithium Americas (LAC), Meta Platforms (META), Advanced Micro Devices (AMD), iSpecimen (ISPC), NVIDIA (NVDA) and Applied Materials (AMAT). Company Calendar Last Earnings5/20/2026Today8/10/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrials Industry Aerospace & Defense Sub-IndustryAerospace & Defense Current SymbolNASDAQ:DFNS Previous SymbolNASDAQ:NUKK CIK1787518 Webwww.nukk.com Phone212-791-4663FaxN/AEmployees12Year Founded2013Profitability EPS (Trailing Twelve Months)($367.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$78.55 million Net MarginsN/A Pretax Margin-1,443.74% Return on Equity-190.60% Return on Assets-40.70% Debt Debt-to-Equity Ratio0.07 Current Ratio0.25 Quick Ratio0.21 Sales & Book Value Annual Sales$5.91 million Price / Sales4.77 Cash Flow$463.75 per share Price / Cash Flow0.08 Book Value($90.93) per share Price / Book-0.41Miscellaneous Outstanding Shares760,000Free Float674,000Market Cap$28.20 million OptionableN/A Beta-5.80 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:DFNS) was last updated on 8/10/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored$8B is moving in... are you?Venture capital investment in US crypto companies hit $7.9 billion last year, up 44 percent from the year befo...Awesomely | SponsoredBarricks gold output fell from 2 million ounces to 719000Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...Golden Portfolio | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredEric Fry’s super simple investing mantraFormer Wall Street money manager Eric Fry says buy and hold investing is outdated. Instead, he built his caree...InvestorPlace | SponsoredI found Rolls-Royce below $2. Now THIS.In 2022, Karim Rahemtulla flagged Rolls-Royce when shares traded below $2 - they later climbed above $10. N...Monument Traders Alliance | SponsoredReal reason Trump banning Chinese modelsPresident Trump's administration is drafting a ban on Chinese-made components used inside American AI data cen...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nukkleus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nukkleus With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
